赖氨酰氧化酶样蛋白2(LOXL2)重组蛋白
Recombinant Lysyl Oxidase Like Protein 2 (LOXL2)
LOR2; WS9-14; Lysyl oxidase homolog 2; Lysyl oxidase-related protein 2; Lysyl oxidase-related protein WS9-14
- 编号RPF552Hu01
- 物种Homo sapiens (Human，人) 相同的名称，不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位分泌, 细胞外基质
- 预测分子量12.5kDa
- 实际分子量15kDa(差异分析请参阅说明书)
- 片段与标签Gln323~Pro427 with N-terminal His Tag
- 缓冲液成份磷酸盐缓冲液（pH7.4，含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.）
- 性状冻干粉
- 纯度> 97%
- 等电点5.9
-
应用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，请参见活性蛋白。 - 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 1200 ¥ 3000 ¥ 6000 ¥ 18000 ¥ 45000
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
-
产品包装(模拟)
-
产品包装(模拟)
-
SDS-PAGE图
-
通过ISO 9001、ISO 13485质量体系认证
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
增值服务
相关产品
| 编号 | 适用物种：Homo sapiens (Human，人) | 应用(仅供研究使用，不用于临床诊断！) |
| RPF552Hu01 | 赖氨酰氧化酶样蛋白2(LOXL2)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPF552Hu02 | 赖氨酰氧化酶样蛋白2(LOXL2)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAF552Hu01 | 赖氨酰氧化酶样蛋白2(LOXL2)多克隆抗体 | WB; IHC; ICC; IP. |
| PAF552Hu02 | 赖氨酰氧化酶样蛋白2(LOXL2)多克隆抗体 | WB; IHC; ICC; IP. |
| SEF552Hu | 赖氨酰氧化酶样蛋白2(LOXL2)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMF552Hu | 赖氨酰氧化酶样蛋白2(LOXL2)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| BMC Cancer. | Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.12 [Pubmed: 24007603] |
| Current Eye Research | High Glucose Induced Differential Expression of Lysyl Oxidase and Its Isoform in ARPE-19 Cells [Pubmed: 22966818] |
| Curr Eye Res | Correlation of Aqueous Humor Lysyl Oxidase Activity with TGF-ß Levels and LOXL1 Genotype in Pseudoexfoliation [Pubmed:27116380] |
| BMC Cancer | Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study [Pubmed:29558905] |
| Laryngoscope | Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma [Pubmed: 31219623] |
留言咨询
